{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:39:28Z","timestamp":1787009968667,"version":"build-2736575974"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1097\/ftd.0000000000000216","type":"journal-article","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T06:48:54Z","timestamp":1430290134000},"page":"756-765","source":"Crossref","is-referenced-by-count":29,"title":["Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration\u2013Time Curve to the Minimum Inhibitory Concentration \u2265400 Target"],"prefix":"10.1097","volume":"37","author":[{"given":"Jiraganya","family":"Bhongsatiern (JJ)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Stockmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica K.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent E.","family":"Korgenski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Spigarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj B.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M. T.","family":"Sherwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 2","key":"R1-9-20210129","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0378-3782(12)70019-1","article-title":". Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units.","volume":"88","author":"Hornik","year":"2012","journal-title":"Early Hum Dev"},{"key":"R2-9-20210129","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.pcl.2012.12.003","article-title":"Neonatal infectious diseases: evaluation of neonatal sepsis.","volume":"60","author":"Camacho-Gonzalez","year":"2013","journal-title":"Pediatr Clin North Am"},{"key":"R3-9-20210129","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1542\/peds.110.2.285","article-title":". Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network.","volume":"110","author":"Stoll","year":"2002","journal-title":"Pediatrics"},{"key":"R4-9-20210129","first-page":"382","article-title":"White R, et al..","volume":"24","author":"Clark","year":"2004","journal-title":"Nosocomial infection in the NICU: a medical complication or unavoidable problem J Perinatol"},{"key":"R5-9-20210129","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2165\/00148581-200305110-00002","article-title":"Neonatal sepsis: epidemiology and management.","volume":"5","author":"Baltimore","year":"2003","journal-title":"Paediatr Drugs"},{"key":"R8-9-20210129","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40272-013-0057-x","article-title":". Considerations in the pharmacologic treatment and prevention of neonatal sepsis.","volume":"16","author":"Stockmann","year":"2014","journal-title":"Paediatr Drugs"},{"key":"R10-9-20210129","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/600877","article-title":". Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.","volume":"49","author":"Rybak","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R11-9-20210129","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":". Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R12-9-20210129","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":". New equations to estimate GFR in children with CKD.","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R13-9-20210129","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3109\/14767058.2012.657277","article-title":". Creatinine reference values in ELBW infants: impact of quantification by Jaffe or enzymatic method.","volume":"25","author":"Allegaert","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R14-9-20210129","first-page":"1068","article-title":". External evaluation of population pharmacokinetic models of vancomycin in neonates: the transferability of published models to different clinical settings.","volume":"74","author":"Zhao","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"R16-9-20210129","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/jcph.281","article-title":". Implications of serum creatinine measurements on GFR estimation and vancomycin dosing in children.","volume":"54","author":"Neuman","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"R17-9-20210129","first-page":"S1","article-title":"KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R18-9-20210129","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/clpt.1994.120","article-title":". Population pharmacokinetics of vancomycin in neonates.","volume":"56","author":"Seay","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"R19-9-20210129","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/00912700122010898","article-title":". The influences of renal function and maturation on vancomycin elimination in newborns and infants.","volume":"41","author":"Capparelli","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"R20-9-20210129","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1128\/AAC.48.4.1159-1167.2004","article-title":". Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates.","volume":"48","author":"Kimura","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R21-9-20210129","first-page":"75","article-title":"Van den Anker JN, et al..","volume":"63","author":"Anderson","year":"2007","journal-title":"Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance Br J Clin Pharmacol"},{"key":"R22-9-20210129","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/FTD.0b013e31806db3f5","article-title":". Renal drug clearance in preterm neonates: relation to prenatal growth.","volume":"29","author":"Allegaert","year":"2007","journal-title":"Ther Drug Monit"},{"key":"R23-9-20210129","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1128\/AAC.01370-09","article-title":". Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination.","volume":"54","author":"Lo","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R24-9-20210129","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2125.2010.03736.x","article-title":"Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline.","volume":"70","author":"Marques-Minana","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"R25-9-20210129","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1007\/s11095-014-1361-z","article-title":". Simultaneous pharmacokinetic modeling of gentamicin, tobramycin and vancomycin clearance from neonates to adults: towards a semi-physiological function for maturation in glomerular filtration.","volume":"31","author":"De Cock","year":"2014","journal-title":"Pharm Res"},{"key":"R26-9-20210129","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s11095-013-1197-y","article-title":". A neonatal amikacin covariate model can be used to predict ontogeny of other drugs eliminated through glomerular filtration in neonates.","volume":"31","author":"De Cock","year":"2014","journal-title":"Pharm Res"},{"key":"R27-9-20210129","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1128\/AAC.03620-14","article-title":". Association between vancomycin trough concentration and AUC in neonates.","volume":"58","author":"Frymoyer","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R28-9-20210129","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1097\/INF.0b013e318286378e","article-title":". Improved vancomycin dosing in children using area under the curve exposure.","volume":"32","author":"Le","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R29-9-20210129","first-page":"1017","article-title":". Population-based pharmacokinetic modelling of vancomycin in children with renal Insufficiency.","volume":"2","author":"Le","year":"2014","journal-title":"J Pharmacol Clin Toxicol"},{"key":"R30-9-20210129","doi-asserted-by":"crossref","first-page":"831","DOI":"10.6061\/clinics\/2012(07)21","article-title":"Clinical pharmacokinetics of vancomycin in the neonate: a review.","volume":"67","author":"Pacifici","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"R31-9-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11596390-000000000-00000","article-title":". Vancomycin: a review of population pharmacokinetic analyses.","volume":"51","author":"Marsot","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"R32-9-20210129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-2607(98)00067-4","article-title":"Xpose-an S-PLUS based population pharmacokineticpharmacodynamic model building aid for NONMEM.","volume":"58","author":"Jonsson","year":"1999","journal-title":"Comput Methods Programs Biomed"},{"key":"R34-9-20210129","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003088-200443130-00005","article-title":". Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.","volume":"43","author":"Moise-Broder","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"R35-9-20210129","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/adc.51.11.875","article-title":". Estimation of glomerular filtration rate from plasma creatinine concentration in children.","volume":"51","author":"Counahan","year":"1976","journal-title":"Arch Dis Child"},{"key":"R36-9-20210129","first-page":"903","article-title":"Coulais Y, et al..","volume":"17","author":"Leger","year":"2002","journal-title":"Estimation of glomerular filtration rate in children Pediatr Nephrol"},{"key":"R37-9-20210129","doi-asserted-by":"crossref","first-page":"F221","DOI":"10.1136\/fn.81.3.F221","article-title":"Pharmacokinetics and dose requirements of vancomycin in neonates.","volume":"81","author":"Grimsley","year":"1999","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R38-9-20210129","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1067\/mcp.2000.105353","article-title":". Vancomycin population pharmacokinetics in neonates.","volume":"67","author":"de Hoog","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"R39-9-20210129","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/j.1875-9114.2012.01029.x","article-title":". Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.","volume":"32","author":"Mehrotra","year":"2012","journal-title":"Pharmacotherapy"},{"key":"R40-9-20210129","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1542\/peds.96.6.1156","article-title":". Assessment of glomerular filtration rate in preterm infants by serum creatinine: comparison with inulin clearance.","volume":"96","author":"van den Anker","year":"1995","journal-title":"Pediatrics"},{"key":"R41-9-20210129","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1038\/psp.2013.14","article-title":"Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods.","volume":"2","author":"Mould","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"R42-9-20210129","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00001432-200406000-00011","article-title":"Coagulase-negative staphylococcal disease: emerging therapies for the neonatal and pediatric patient.","volume":"17","author":"Weisman","year":"2004","journal-title":"Curr Opin Infect Dis"},{"key":"R43-9-20210129","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1128\/JCM.41.10.4660-4665.2003","article-title":". Decreased vancomycin susceptibility of coagulase-negative staphylococci in a neonatal intensive care unit: evidence of spread of Staphylococcus warneri.","volume":"41","author":"Center","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R44-9-20210129","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/INF.0b013e3181906e40","article-title":". Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate.","volume":"28","author":"Frymoyer","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R45-9-20210129","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1345\/aph.1R211","article-title":". Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 mcgmL to vancomycin: old (trimethoprimsulfamethoxazole) versus new (daptomycin or linezolid) agents.","volume":"46","author":"Campbell","year":"2012","journal-title":"Ann Pharmacother"},{"key":"R48-9-20210129","first-page":"113","article-title":"Althahabi R, et al..","volume":"65","author":"Srivastava","year":"2009","journal-title":"Impact of standardization of creatinine methodology on the assessment of glomerular filtration rate in children Pediatr Res"},{"key":"R49-9-20210129","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1128\/AAC.01485-12","article-title":". Vancomycin AUCMIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia.","volume":"57","author":"Holmes","year":"2013","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T09:44:06Z","timestamp":1651830246000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201512000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000216","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}